What Impact Will SCOTUS Ruling Have on Philadelphia Out-of-State Plaintiffs?
Of the 3,884 prescription drug lawsuits filed in Philadelphia filed between January and the end of May in 2017, 94 percent of plaintiffs live outside of Philadelphia. The U.S. Supreme Court’s Bristol Myers-Squibb ruling puts their future in question, writes Legal Newsline in Forbes.
The Philadelphia Complex Litigation Center has seen a growth of out-of-state plaintiffs to date in 2017. In 2016, 74 percent of pharmaceutical plaintiffs were not from Pennsylvania. That number is up 20 points this year.
On June 19, the Supreme Court ruled 8-1 in favor of the pharmaceutical company, saying plaintiffs outside of California cannot sue in that state. James Beck of Reed Smith said the ruling puts “major limits on plaintiffs’ ability to forum-shop in this manner.”